Analysts expect over 2018 rising revenue Roche, relatively high dividend

Tomorrow the Swiss Roche will publish its past quarter's figures. For this year Roche 's revenue will be around 53,46 billion CHF. This is according to the average of the analysts' estimates. This is slightly more than 2016's revenue of 50,58 billion CHF.

Historical revenues and results Roche plus estimates 2018

financial analysis

The analysts expect for 2018 a net profit of 13,14 billion CHF. According to most of the analysts the company will have a profit per share for this book year of 15,49 CHF. So the price/earnings-ratio equals 14,97.

Huge dividend Roche

For this year the analysts expect a dividend of 8,6 CHF per share. The dividend yield is then 3,71 percent. The average dividend yield of the pharmaceutical companies equals a limited 1,17 percent.

Latest estimates around 291 CHF

The most recent recommendations for the pharmaceutical company are from Barclays , Independent Research and Liberum.

Roche 's market value equals around 160,51 billion .

Historical stock prices Roche

financial analysis roche

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.